Topics
Sector
Geography
Subject

Videos Library

Event Videos

1161
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

Please find the latest videos from entire, recent NextLevel LifeSciences events.

MEDAFFAIRS LEADERS FORUM USA

Boston, Massachusetts - July 31 - August 2, 2018
Presentation

Data and strategic perspective

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Steve Decker
Director, Business Development
Voxx Analytics

Presentation

A cigar is just a cigar...or is it?: Turbocharging MSL Communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE

Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.

Speaker

Pamela Peters
Senior Director, Medical Affairs Strategic Solutions
Medscape

Market Access in Latin America Leaders Forum

Brazil - June 13-14, 2018
Presentation

The economic impact of value on different payment models

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Overview of main payment mechanisms
  • Basics of hospital financing
  • Activity-based payments: DRG
  • Value-based payments
  • Shift to value: is it happening now?
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Value-Based Reimbursement: including a new procedure in the Brazilian Public Healthcare System (SUS)

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Quantification of the unmet need for SUS.
  • Development of cost-effectiveness and budget impact analyses.
  • Potential scenarios for SUS with inclusion of technology.
  • Project results and next steps.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

AI & BLOCKCHAIN Applications in Pharma R&D

Switzerland - May 30-31, 2018

PharmAccess Leaders Forum Spring

London, UK - April 17-18, 2018
Presentation

Changing Trends in Real World Evidence

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Payer expectations.
  • The regulatory landscape.
  • Access to data.
  • The Increasing voice of the patient.
  • What is in store for sponsor-CRO partnerships?
Speaker

Noolie Gregory
Exec Dir, Client Engagement
Syneos Health, UK

Presentation

Early Access Programs – as a valuable component of market access and launch strategy

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Clinical
Availability: FREE
  • Understand how these programs have been used extensively by pharma companies to address unmet medical need, but have broader market access benefits including another source of real world data.  This session will help people understand the basics about EAPs, the current landscape and industry trends around EAPs, and the types of data that various companies are capturing.  A case study will be provided.
Speaker

Kieron Lewis
Global Business Development Director
Clinigen, UK

Nordic Market Access Leaders Forum

Stockholm, Sweden - April 18-19, 2018
Presentation

Real world evidence: Opportunities and challenges with registry data

Related topics: Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE

- Real world data solutions in the post-marketing world: the multiple sclerosis experience

- Introduction to the MSBase international registry

- Methods for separating drug signals from bias in observational data

- Pharma / disease registry collaborations in comparative effectiveness analyses

- Big data: Big MS and beyond

Speaker

Tim Spelman
Senior Scientist
Synergus

MedAffairs Leaders Forum (Spring)

London, UK - February 27 - March 1, 2018
Presentation

Leading MSLs to the best of their potential

Related topics: Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
  • Internal training
  • Engagement tool
  • Keeping the conversation going
Speakers

Annie Rankin
Client Partnerships Lead
Succinct Medical Communications

Gavin Kenny
Account Director
Succinct Medical Communications

Presentation

The power of consistent communication with HCPs and patients

Related topics: Medical Affairs & Stakeholder Engagement, Patient-Centricity & Care
Availability: FREE
  • Keeping consistency in communications with both HCPs and patients to maximise high quality patient-HCP conversations
Speakers

Katie Corbin
Managing Director
Succinct Medical Communications

Richard Jones
Patient Services Director
The Earthworks (an OPEN Health Company)

MedTech Commercial Leaders Forum Europe

Zürich, Switzerland - February 20-21, 2018
Presentation

From NPS to an actionable customer centric listening program: A global approach

Related topics: MedTech, Commercial
Availability: FREE
  • Moving beyond NPS
  • Engaging a global team to get local customer insight
  • Maintaining the focus on the customer
  • Driving the global process forward.
  • It’s not just the numbers: Tell the story of the customer
Speakers

Shane West
VP Client Relations
Cetas Healthcare Insights, Norway

Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, India

Presentation

Opportunities for digital technologies and services to drive value and access for Medtech

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • What does the new world of medtech and digital health look like?
  • How can digital technologies and services enhance the value of devices in a meaningful way to payers?
  • How will these innovative solutions be regulated and reimbursed?
Speaker

Anne Smart
Managing Director
ClearView Healthcare Partners, USA

R&D Data Intelligence Leaders Forum

Basel, Switzerland - January 23-24, 2018
Presentation

Challenges and opportunities for successful Real World Evidence strategy

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Nourdine Bouzekri
Principal Industry Consultant
SAS, France

Presentation

Putting the patient/citizen into the driving seat

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
  • The key elements to leverage the potential of electronic health care data: Where is the trust?
  • Regulations which might support it: GDPR and other regulations
  • Who are the partners/stakeholders and their major responsibilities?
  • Democratization of the analytics and data: Patients view and the citizen handle it?
  • Ethical consideration about not being in a position using the data: Another view or how interests might need a balance and who might be in charge?
Speaker

Peter Grolimund
Sr. Life Science Industry Consultant
ThinkBig Analytics (a Teradata company)

MedTech Access Leaders Forum

Berlin, Germany - December 5-7, 2017
Presentation

Enabling economic selling

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • What is the role of market access in economic selling?
  • The challenge of quantifying value.
  • Building effective tools and training methods.
  • Partnering with commercial teams.
  • Case studies: Selling value in the UK and Germany.
Speaker

Ernesto M. Nogueira
Managing Director
Value Connected, Netherlands

Presentation

Real World Evidence the key to smart medical device market access

Related topics: MedTech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • It is all about the quality of the data.
  • RWE to understand target indication and plausibility of clinical trial success.
  • Single arm / registry to comparative effectiveness data.
Speaker

Mattias Kyhlstedt
CEO
Synergus AB, Denmark

MedTech Commercial Leaders Forum USA

Princeton - New Jersey - November 6-8, 2017
Presentation

Preparing commercial teams to demonstrate value, not features

Related topics: MedTech, USA, Commercial
Availability: FREE
  • More professional purchasers and decision makers need a different approach
  • Why price is not the priority for providers (even though it seems so)
  • Developing the value message: Quantifying benefits
  • Roadmap to preparing commercial teams to use value to justify price
  • Best practices from real case studies
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Embedding market access into the mergers & acquisitions process

Related topics: MedTech, USA, Market Access & HEOR
Availability: FREE
  • Market access supporting key value processes
  • The mergers & acquisitions process
  • Key issues examined during due diligence
  • Anonymised case studies
Speaker

Rob Wenthold
Vice President
Boston Healthcare Associates

PharmaValue Stakeholder Forum

Berlin, Germany - 10 October, 2017

MedAffairs Leaders Forum (Autumn)

Berlin, Germany - October 10-13, 2017
Presentation

Medical affairs information strategies for medical devices and how to take advantage of new requirements

Related topics: MedTech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
Speaker

William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group

Presentation

A pinch of strategy: Perfecting the recipe for success in medical affairs communications

Related topics: Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
  • The revolution in our kitchen: The changing landscape of medical Affairs.
  • Introducing new ingredients: A new blend of responsibility for medical affairs leaders.
  • Prepare, mix, bake: Using the right approach to create an effective and affective medical affairs plan.
  • Serving suggestions: How powerful communications can change patients’ lives.
Speakers

Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK

Rhiannon Meaden
Head of Commercial Development
Complete HealthVizion, UK

PharmAccess Leaders Forum (Autumn)

Berlin, Germany - October 10-12, 2017
Presentation

Future market access excellence: Enabling a dynamic organisation

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
  • New organisational capability needs to address major market changes.
  • Optimising global strategy and local agility: Updated planning and governance structures.
  • Cross-functional leadership and aligned KPIs.
  • Digital tools to drive efficiency, effectiveness and feedback.
Speaker

Chris Easley
Head of Market Access Solutions
Pope Woodhead and Associates Ltd.

Presentation

What’s it worth to you? Assessing value of product attributes through decision-analytic modelling

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • How a product’s characteristics or attributes contribute to both individual willingness to pay and “value” from different perspectives (e.g., stakeholder, society).
  • The various methodologies through which attribute value can be assessed.
  • A real-world case study of how decision-analytic modelling helped a leading medical device company establish the value of a unique product attribute, and by so doing justify higher tender pricing in a key EU market.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

Medical Affairs Leaders Forum USA

Princeton, New Jersey, USA - July 25-27, 2017
Presentation

The role of MSLs in the development of pre-market communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Commercial, Global (non-specific), Medical Science Liaison, Life Sciences (not-specific)
Availability: FREE
  • Medical Affairs and MSL synchronicity: Linking efforts to ensure a positive outcome.
  • MSLs and KOLs: The data sweet spot: Finding balance within the current regulatory environment.
  • The role of MSLs in audience engagement: Strategic & tactical approaches to engagement.
  • MSL-directed educational communications: An appropriate path forward.
  • Measuring the impact of MSL-driven activities: Applying metrics to establish impact.
Speaker

Tim Day
Principal 
Innovative Strategic Communications

Presentation

Achieving world-class execution in medical affairs

Related topics: Pharmaceutical/Biotech, USA, Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE

With the rise of medical affairs as healthcare’s core scientific partner, industry leaders are reimagining their organizations to achieve a world-class standard–and deliver greater value. Learn how to align engagement strategies to healthcare stakeholders’ scientific goals and interests, based on actionable insights.

Speakers

Robert Groebel 
Vice President - Global Medical Strategy 
Veeva

Brian Harper
Senior Director, Medical Content Strategy
Veeva 

PharmAccess Leaders Forum (Spring)

Milan, Italy - May 3-5, 2017
Presentation

The Patient as the Payer: What drives patients’ willingness-to-pay?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Patient-Centricity & Care
Availability: FREE
Speaker

Adrien Gras
Vice President Europe, Market Access
GFK, UK

Presentation

Bio-similar, but different: Establishing (or defending) value through Multi-Criteria Decision Analytic (MCDA) modelling

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
  • How the complex characteristics of biologics (and biosimilars) contribute to perceived value to different stakeholders.
  • The salient issues facing Upstarts (marketers of biosimilars) and Defenders (marketers of “original” biologics) in communicating comparative worth to stakeholders.
  • How MCDA modelling methods can assist both groups in better defining and communicating value.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

MedTech Commercial Leaders Forum (Europe)

Zurich, Switzerland - February 20-22, 2017
Presentation

Success case study: Driving bottom-line surge using salesforce analytics, salesforce sizing and deployment issues

Related topics: MedTech, Commercial, Global (non-specific)
Availability: FREE
  •  Promotion response modelling for ROI on sales calls to derive optimal size.
  •  Territory alignment based on Potential Index and Workload Index.
  •  Incentive design for salesforce based on fairness, motivation and financial risk.
Speaker

Sumit Mehta
Managing Director
Cetas Healthcare Insights

Presentation

Improving commercial effectiveness at scale: A Boston Scientific case study

Related topics: MedTech, Commercial, Global (non-specific)
Availability: FREE
  •  Identifying commercial learning challenges.
  •  Shifting middle performers.
  •  Implementing solutions to support continuous commercial learning at scale.
  •  The path to continued commercial effectiveness.
Speakers

Jay Bratcher 
Training Manager, New Cardio, Europe 
Boston Scientific, UK

Michael Quann
Director Strategic Account
Qstream, Ireland

Medical Affairs Leaders Forum (Spring)

Zürich, Switzerland - February 28 - March 2, 2017
Presentation

A matter of perspective: Evolving the MSL role for the long-term development of next-generation KOLs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Medical Science Liaison
Availability: FREE
  • What is the role of an MSL today in developing strategic relationships with KOLs.
  • Learn what a typical ‘day in the life’ of an MSL is like.
  • Is the role of an MSL here to stay for the long term?
Speaker

Sital Kotecha
Medical Strategy Director, Europe
Veeva Systems, UK

Presentation

Pre-Market Communications: Reaching your audience in today’s complex environment

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • The importance and benefits of an effective pre-market communication plan.
  • The when, where and how of the various elements who need to be engaged.
  • Development and implementation of the plan: Where the magic happens and results are driven!
  • The essential elements to any pre-market communication plan.
  • The need for achieving balance between the speed, timing and volume of pre-market communications.
Speaker

Tim Day
CEO & Principal
Innovative Strategic Communications, USA

R&D Data Intelligence Leaders Forum

Basel, Switzerland - January 24-26, 2017
Presentation

Opportunities and challenges using unsolicited, self-reported, health outcomes data from open web-based media sources

Related topics: Pharmaceutical/Biotech, IT & Big Data, Global (non-specific), Digital & Technology
Availability: FREE
  • An ever-increasing number of individuals routinely contribute and consume solicited and unsolicited information about a variety of health-related issues using a wide range of internet and social media channels.
  • Personal web-based reports on health status, symptoms, treatments and associated interventions may provide a rich source of data to support discovery, clinical development and post marketing analytics.
  • A key challenge in the applicability and utility of these data is related to the veracity, accuracy and reliability of information collected from web-based media sources.
Speaker

Mark Wolff
Advisory Industry Consultant, Chief Health Analytics Strategist
Health & Life Sciences Global Practice, SAS Institute, USA

Presentation

Leading patient engagements: From patient data analytics to mHealth interventions

Related topics: Pharmaceutical/Biotech, IT & Big Data, Global (non-specific), Patient-Centricity & Care, Digital & Technology
Availability: FREE
Speaker

Alexander Frenzel
Senior Manager, Business Development T&A, QuintilesIMS, Germany

MedTech Access Leaders Forum

Berlin, Germany - December 6-8, 2016
Presentation

Market access challenges and opportunities for clinical applications of Next Generation Sequencing (NGS)

Related topics: MedTech, Diagnostics, Europe, Market Access & HEOR
Availability: FREE
  • Review of benefits of NGS and challenges associated with securing payment for multiplex testing technologies.
  • Overview of EU5 payment systems for diagnostics.
  • Case studies: Payment for NGS oncology applications in Germany and France.
  • Case studies: Reimbursement initiatives for non-invasive, prenatal testing.
  • Best practices/insights for innovators.
Speaker

Charles Mathews
Vice President
Boston Healthcare, USA

Presentation

Translating hospitals’ needs into actual value stories

Related topics: MedTech, Europe, Market Access & HEOR
Availability: FREE
  • Identifying decision-makers’ needs.
  • Assessing the relevant data to support claims.
  • Building a concrete value story.
  • Next steps: Teams, not tools, demonstrate value.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

Medical Affairs Leaders Forum (Autumn)

London, UK - October 18-20, 2016
Presentation

Live events in the digital age: Case Study of a catalyst for building integrated and sustained engagement with healthcare professionals

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
  • The problem: High investment with limited reach and high output that is short-lived.
  • The objective: Capitalising on events to extend the value through sustained targeted engagement.
  • The strategy: An end-to-end programme designed to be multicontent, multi-event & multi-channel.
  • The evidence: Research and metrics that supports this approach and better outcomes.
Speaker

Tiberio Catania
Commercial Director
EPG Health Media, UK

Presentation

Breaking the “fail-cycle” of KOL CRM Solutions

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE

A plethora of studies suggest that an astonishing 50 – 75% of all CRM implementations fail in some form. So we started our KOL CRM development programme with the assumption “why should ours be any different?” Our two-year case study highlights the many challenges we (vendor & our clients) encountered in the medical affairs context, our many failings, and the innovations we built to overcome them. We’ll also present a simple framework for Medical Affairs to help maximise the success of CRM implementations to boost external expert management.

Speaker

Sanjay Singhvi
Director, System Analytic, UK

PharmAccess Leaders Forum (Autumn)

Berlin, Germany - September 27-29, 2016
Presentation

Biosimilar, but different: Establishing (or defending) value through multi-criteria decision analytic (MCDA) modelling

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
  • How the complex characteristics of biologics (and biosimilars) contribute to perceived value to different stakeholders.
  • The salient issues facing upstarts (marketers of biosimilars) and defenders (marketers of “original” biologics) in communicating comparative worth to stakeholders.
  • How MCDA modelling methods can assist both groups in better defining and communicating value.
Speaker

Mason W. Russell
MAPE, Vice President
Truven Health Analytics, USA

Presentation

Cell & gene therapies: A global perspective of HTA, funding & reimbursement challenges

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Overview of cell & gene therapies.
  • Health technology assessment & cost effectiveness challenges.
  • Who pays? Healthcare system determinants of funding / reimbursement.
  • Affordability: Pricing and budget impact challenges.
  • Lessons learned: Early case studies.
Speaker

Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.

Market Access in Latin America Leaders Forum

São Paulo, Brazil - July 12-14, 2016
Presentation

Is your market access organization ready for the evolving access challenges in Latin America?: A primer on organizational development to reflect marketplace changes.

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Latin America
Availability: FREE
Speakers

Miguel Martin de Bustamante
Associate, CBPartners

Sandeep Duttagupta
Vice President, CBPartners

Medical Affairs Leaders Forum (Asia)

Singapore - July 20-21, 2016
Presentation

Navigating post-marketing requirements worldwide: What to anticipate as you move towards submission

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  • Review of post-marketing requirements in the USA, Europe, and South Korea.
  • How to interpret the demand of the authorities,
  • Proactive planning to drive design.
  • Real-world case studies from the USA, Europe and South Korea.
Speaker

Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services,
PRA Health Sciences

Presentation

Practical strategies for implementing RWE studies in Asia Pacific

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  • Differences between real-world evidence studies and randomized controlled trials.
  • Asia Pacific country specific examples of real-world evidence studies.
  • Local regulations on study approval and execution.
  • KOL value and working with investigators in APAC.
Speakers

William Maier
Chief Scientific Officer, Mapi Group, UK

Isabelle Grau
Director, Real World Evidence APAC, Mapi Group, Australia

Nordic Market Access Leaders Forum

Stockholm, Sweden - April 19-20, 2016

PharmAccess Leaders Forum (Spring)

London, UK - April 26-28, 2016
Presentation

Global review of innovative pricing arrangements: Shifting dynamics and new considerations

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • Payer perception/considerations of innovative pricing in the context of health budget pressures.
  • Analytics overview of geographies and therapeutic areas where key changes are occurring.
  • Key strategic lessons over how these agreements are being designed.
Speaker

Gustav Ando
Vice President of Life Sciences
IHS

Presentation

Understand the real drivers of HTA decision-making in oncology: What clinical and economic factors influence positive vs negative recommendations?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Oncology
Availability: FREE
  • How do payers evaluate products in an increasingly crowded marketplace.
  • How successful are companies in getting new products approved?
  • Comparing major payers: Where are similarities and where are the difference in their evaluations?
  • Do companion diagnostics make a difference in the approval success rate?
Speaker

Anke van Engen
Principal, Advisory Services, Quintiles, Netherlands

Medical Affairs Leaders Forum (Spring)

Berlin, Germany - February 22-23, 2016
Presentation

Leveraging support programmes to enhance medical communications

Related topics: Pharmaceutical/Biotech, Europe, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • How pharma can utilise digital programmes to support publication strategy.
  • Using materials and real world evidence to reach new KOL audiences.
Speaker

Ian Smyth
Director
MEDNET Consult

Presentation

The changing face of KOL partnerships

Related topics: Pharmaceutical/Biotech, Europe, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Compliance and transparency regulations are causing many pharmaceutical companies to re-evaluate how they pay and partner with external experts.
  • How do we define a KOL and what are models for effective KOL engagement in the changing environment?
Speaker

Rob Barker
CEO, Succinct Medical Communications, UK

Medical Device Commercial Leaders Forum (Europe)

Brussels, Belgium - February 16-18, 2016
Presentation

Six key buyer trends reshaping MedTech selling & pricing

Related topics: MedTech, Europe, Market Access & HEOR, Commercial
Availability: FREE

The MedTech industry is at an inflection point. Healthcare providers at every level are professionalising their procurement and creating tectonic shifts in their demands on your pricing, sales, and tendering and contracting operations. While the industry appears to be aware of these shifts and what the impacts will be, many MedTech companies are struggling to identify and prioritise the changes they need to make to stay ahead of these trends without sacrificing revenue or growth.

Speaker

Peter Zimmermann
Director Customer Success Europe
Model N, Switzerland

Presentation

Developing a commercial model based on value

Related topics: MedTech, Europe, Market Access & HEOR, Commercial
Availability: FREE
  • Early stage or product launch: When is the right moment to focus on value?
  • Identifying the key value propositions to drive the market.
  • Building the relevant economic data to support value claims.
  • Case example: From feature-centric to value-based model
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

R&D Big Data Leaders Forum

London, UK - January 19-21, 2016
Presentation

Breaking the classical barriers to collaboration and scientific discovery: Distance and data size

Related topics: Pharmaceutical/Biotech, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE

Life sciences organisations need to dramatically reduce analytics time and speed up clinical interventions, but most still rely on shipping physical disks due to inherent problems with existing networks and transfer protocol inefficiencies. Spending days to transport data is not a viable option, this session will explore technology infrastructure for file transfer that will catalyse the transition from 1GbE to 10GbE and beyond.

  • Enabling geographically distributed collaborative teams to exchange huge data sets at maximum speed, regardless of distance and network conditions.
  • Utilising proven, secure and reliable transfer technology, widely adopted for business-critical data movement.
  • Transferring large data sets, including next-generation genomic sequencing sets, amounting to hundreds of gigabytes.
Speaker

Per Hansen
Regional Manager Sales Engineering EMEA, Aspera (an IBM Company),UK

Presentation

From Big Data to precision medicine: Trends, challenges & opportunities

Related topics: Pharmaceutical/Biotech, Diagnostics, Clinical, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
Speaker

Thomas Wilckens
Chief Executive Officer, CSO & Founder, InnVentis, Germany

MedTech Access Leaders Forum

December 8-10, 2015
Presentation

Leveraging Real-World Evidence (RWE) in medical device reimbursement

Related topics: MedTech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • What do we mean by RWE?
  • Usefulness and limitations of RWE in supporting medical device reimbursement.
  • Case studies of the successful use of RWE in device reimbursement.
  • Summary.
Speaker

Stuart Mealing
Principal Economist, European Practice Lead
ICON, UK

Presentation

Building economic evidence towards compelling value propositions

Related topics: MedTech, Europe, Market Access & HEOR
Availability: FREE
  • Early stage or commercialisation: When is the right moment to focus on economic evidence?
  • Identifying what decision-makers are looking for.
  • Less is more: Identifying the relevant data to support value claims.
  • Case example: From evidence to compelling value proposition.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

Medical Affairs Leaders Forum (Autumn)

October 21-22, 2015
Presentation

NICE’s Medical Technologies Evaluation Programme: A global view of a national HTA

Related topics: MedTech, Europe, UK, Market Access & HEOR
Availability: FREE
  • How applicable is MTEP outside of England?
  • How does MTEP compare to other MedTech HTA?
  • What benefit is there to submitting to MTEP?
Speaker

Joanna Entwistle
Principal Consultant, GFK Market Access, UK

Presentation

Enhancing your medical affairs communications practices

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE

How do we avoid the greatest threat to carefully crafted medical strategy – the inevitable boiling down of delicately nuanced arguments into bullet points, charts and tables? To the outside observer it appears to be largely generic and is hardly reassuring to senior stakeholders who must bless it, or clear to those who must ultimately implement it. This presentation will discuss how to create and communicate your medical strategy in a way that informs and inspires the reader.

Speaker

Robert Barker
CEO, Succinct Medical Communications, UK

PharmAccess Leaders Forum (Autumn)

October 13-15, 2015
Presentation

HTA, funding & reimbursement of cell & gene therapies: A global perspective

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Health technology assessment challenges in assessing clinical and cost effectiveness of cell / gene therapies.
  • Who pays? Healthcare system determinants of funding/reimbursement paradigm.
  • Affordability: Pricing and budget impact challenges
Speaker

W. Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.

Presentation

Central and Eastern Europe: Diversity to tame, market access potential to unveil

Related topics: Pharmaceutical/Biotech, MedTech, Europe, Market Access & HEOR, Central Eastern Europe
Availability: FREE
  • Regional diversities in approaches to public funding decision making.
  • Comparative measures to enable informed allocation of company strategic efforts.
  • Analysis of public funding decision making practice as a tool to identify risks and opportunities and to provide unbeatable arguments to CEE decision makers
Speaker

Norbert Wilk
Director, Market Access Consulting
Arcana Institute, Poland

Medical Affairs Leaders Forum Asia

Singapore - August 4-5, 2015
Presentation

Mapping real-world centers: Can it be done?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
Speaker

Karen Wai
Vice President, Regional Managing Director Real-World & Late Phase Research, Asia Pacific
Quintiles, Singapore

Presentation

RWE in Asia: Has its time finally come?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  •  Current state of RWE in Asia markets.
  •  Key trends and how it is evolving.
  •  What this means for healthcare companies.
Speaker

Sheryl Jacobson
Asia Head of Life Science and Healthcare Consulting 
Deloitte

Clinical Research in Turkey Middle East and North Africa Leaders Forum

Dubai - United Arab Emirates - June 8-9, 2015
Presentation

The importance of achieving recruitment targets in MENA

Related topics: Pharmaceutical/Biotech, Clinical, Middle East
Availability: FREE
  •  Why is recruitment important?
  •  Issues seen in studies (generally not just MENA).
  •  What are the possible reasons for this?
  •  Are there differences between MENA and ROW in patient recruitment numbers and retention rates?
  •  How could we actively prevent these issues?
  •  Case studies (both good and bad) & lessons learned.
Speaker

Myriam El-Khazen
General Manager 
INC Research, Greece

Market Access & Commercial Excellence Forum Asia

Singapore - August 5-6, 2015
Presentation

Building the market to gain market access in Asia-Pacific countries: From a transactional player to a strategic partner

Related topics: MedTech, Market Access & HEOR, Asia Pacific
Availability: FREE
  • What value does your technology bring to address the needs of the country’s health system?
  • How can you develop the market to create a receptive and favorable environment for your technology?
  • Case study: Established vs. emerging markets.
Speaker

Anne Smart
Director
Navigant, USA

Oncology Clinical Leaders Forum

Brussels, Belgium - May 11-12, 2015
Presentation

Multilateral recruitment approach for early phase oncology trials: Weights and balances

Related topics: Pharmaceutical/Biotech, Clinical, Global (non-specific), Oncology
Availability: FREE
  • Key challenges in early phase oncology recruitment.
  • Therapeutic, supportive and other compounds from trial management perspective.
  • Pros and cons of early phase trials for the investigator and for the cancer patient.
  • Role and potential of professional CPU (Clinical Pharmacology Unit) within indication.
  • Satellite Centre Concept for proper recruitment and controlled quality.
Speaker

Istvan Udvaros 
Medical Director, Project Director of Oncology
SGS LSS Clinical Research, Belgium

Presentation

Mass balance/ADME studies in oncology patients: Successful answers to the challenge in Central and Eastern Europe

Related topics: Pharmaceutical/Biotech, Europe, Clinical, Central Eastern Europe, Oncology
Availability: FREE
  • Patient pharmacology services: Concept and operational set up.
  • ADME concepts, incl. micro-dose and tracer-dose.
  • Underlying dossier requirements incl. preclinical safety package.
  • General design considerations incl. radiodose and radioburden calculation.
  • Devil is in the details: Operational challenges.
  • Selection of geographic region and patient population.
  • Ethical aspects.
Speaker

Agnes Rethy 
Associate Director of Clinical Operations
EDS Patient Pharmacology Services
PRA Health Services

Medical Affairs Leaders Forum Spring

Berlin, Germany - February 26-27, 2015
Presentation

Effectively incorporate communications in product commercialisation

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Developing and implementing a scientific strategy to effectively disseminate evidence and show value and engaging with diverse stakeholders.
  • Understanding how, when, and to whom you communicate evidence.
  • Benefits and challenges of consistent communications.
Speaker

Gillian Boucher
Director, Medical Writing and Editorial
Quintiles

Presentation

What do we call KOLs if we can’t call them “KOLs”?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • The term “KOL”: Too toxic for everyday use, or still the best tool for the job?
  • Results from a survey of pharma and KOLs on the use of terminology alternatives.
  • Should pharma work towards using one universal replacement for the term “KOL”?
  • How does this change the way we engage with KOLs and stakeholders in medical affairs?
  • And what exactly do KOLs think of all this?
Speaker

Sanjay Singhvi  
​Director
System Analytic, UK

Medical Device Commercial Leaders Forum Europe

Brussels, Belgium - February 18-19, 2015
Presentation

Gamification and mobile reinforcement: How science from Harvard Medical School is driving a new approach to healthcare training

Related topics: MedTech, Commercial, Global (non-specific), Digital & Technology
Availability: FREE
  • Ground breaking technology from Harvard Medical School.
  • Used by life science sales teams and healthcare professionals.
  • Extend retention of complex processes and facts from weeks to years.
  • Mobile and social gaming methods to drive adoption and motivation.
  • Maximise return on investment in product training.
     
Speaker

Louella Morton
VP International Sales & General Manager
Qstream

Presentation

Accelerating sales with sales driven marketing

Related topics: MedTech, Commercial
Availability: FREE

In today’s digital age, marketers can use marketing automation and analytics technology enabling them to be hyper-relevant to the customer via online channels. But what happens when the customer schedules a call or meeting with your sales team? How do you know whether or not your content performs well during this offline phase of the customer journey? Learn how to grow your business by supporting your sales and indirect channels with sales driven marketing.

Speaker

Pieterjan Bouten
Chief Executive Officer
Showpad, Belgium

Medical Device Hospital Procurement and Payer Forum

Brussels Belgium - 17 February, 2015

Register to view both free videos and browse premium content (and event documentation).

1161
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!